CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Eagle Pharmaceuticals, Inc.  (EGRX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Eagle Pharmaceuticals's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

Return On Assets (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Total Assets Change 74.68 % 72 % 20.05 % 23.41 % -0.95 %
Y / Y Net Income Change - 4604.27 % - - -
Return On Assets (TTM) 57.27 % 50.98 % 18.47 % 2.48 % -
Total Ranking # 61 # 64 # 192 # 1653 #
Seq. Total Assets Change 4.9 % 46.07 % -1.77 % 16.06 % 3.29 %
Seq. Net Income Change - 379.4 % - - -


Roa Comment
Eagle Pharmaceuticals, Inc. yielded Return on Asset in I. Quarter above company average, at 57.27 %.

Despite detoriation in net income, company improved ROA compare to previous quarter.

Within Healthcare sector 16 other companies have achieved higher return on assets. While Return on assets total ranking has impoved so far to 61, from total ranking in previous quarter at 64.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 7
Sector # 17
S&P 500 # 60

Return On Assets Statistics
High Average Low
57.27 %
26.25 %
2.07 %
(Mar 31 2017)   (Dec. 30, 2015)


You need to upgrade your Flash Player
Financial Statements
Eagle Pharmaceuticals's Equity $ 167 Millions EGRX's Balance sheet
Eagle Pharmaceuticals's Income $ 23 Millions Quarterly EGRX's Income Statement
EGRX's Income by Division See EGRX's Income by Division

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EGRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for EGRX's Competitors
Roa for Eagle Pharmaceuticals's Suppliers
Return On Asstes for EGRX's Customers

You may also want to know
EGRX's Roi EGRX's Inventory Turnover Ratio EGRX's Growth Rates EGRX's Dividend Comparisons
EGRX's Annual Roi EGRX's Profitability Ratios EGRX's Asset Turnover Ratio EGRX's Dividend Growth
EGRX's Roe EGRX's Valuation Ratios EGRX's Financial Strength Ratios EGRX's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2017, within Healthcare Sector ROA
Steadymed Ltd.  145.38 %
International Stem Cell Corp  137.42 %
Capstone Therapeutics Corp.  133.50 %
Greenestone Healthcare Corp  127.56 %
Mannkind Corp  125.49 %
Tenax Therapeutics, Inc.  100.61 %
Neurometrix, Inc.  77.36 %
Elite Pharmaceuticals Inc  70.86 %
Apricus Biosciences, Inc.  61.49 %
Biotime Inc  59.79 %
Eagle Pharmaceuticals, Inc.  57.27 %
First Choice Healthcare Solutions, Inc.  43.68 %
Masimo Corp  43.32 %
Opiant Pharmaceuticals, Inc.  38.01 %
Pro Dex Inc  34.06 %
Supernus Pharmaceuticals Inc  34.06 %
Psychemedics Corp  32.74 %
Enzo Biochem Inc  30.82 %
United Therapeutics Corp  28.08 %
Fonar Corporation  27.43 %
Biotelemetry, Inc.  27.40 %
Regenicin, Inc.  23.99 %
Petmed Express Inc  23.42 %
Gilead Sciences Inc  21.83 %
China Biologic Products, Inc.  20.68 %
Alpha Pro Tech Ltd  20.13 %
Zynex Inc  19.88 %
Titan Pharmaceuticals Inc  19.74 %
Mettler Toledo International Inc  19.42 %
National Research Corporation  19.02 %



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com